Mezcla Raises the Plant-Based Protein Bar with $9.5M in Series B Funding

Why It Matters

The infusion positions Mezcla to capture a fast‑growing protein‑snack market and challenges incumbents with its distinctive texture, potentially reshaping plant‑based bar category dynamics.

Key Takeaways

• Series B raised $9.5M led by Bluestein Ventures
• Revenue growth 128% CAGR since 2022
• Products in 9,000 US stores including Costco
• Pea‑protein puff crisps give unique crunchy texture
• Funds will fuel new flavors and e‑commerce push

Pulse Analysis

The U.S. protein‑snack segment is booming, driven by heightened consumer focus on fitness, weight‑management drugs like GLP‑1, and revised dietary guidelines that raise recommended protein intake. Surveys show 57 % of Americans plan to prioritize protein this year, and household purchases of protein bars have risen 5 % since 2021. This macro‑trend creates fertile ground for innovative brands that can combine nutrition with taste.

Mezcla differentiates itself through a proprietary pea‑protein puff crisp that delivers a rice‑cereal‑like crunch while maintaining the functional benefits of a traditional protein bar. Each 40‑gram bar supplies 10 grams of plant protein, 4‑5 grams of fiber, and 15 % of daily iron, appealing to health‑conscious shoppers seeking clean‑label options. With placement in more than 9,000 retail locations—including Whole Foods, Target, and Costco—Mezcla has already achieved a distribution scale that many niche competitors lack.

The $9.5 million Series B injection equips Mezcla to expand its flavor portfolio, strengthen e‑commerce channels such as Amazon and Misfits Market, and scale its marketing and R&D teams. In a crowded category where brands like Trubar and No Cow vie for shelf space, Mezcla’s unique texture and rapid growth trajectory could accelerate its ascent to a category leader. Moreover, its partnership with The Hunger Project adds an ESG dimension that resonates with increasingly purpose‑driven consumers, enhancing brand equity as the plant‑based market matures.